We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$15.2B
AUM Growth
+$1.14B
(+8.1%)
Cap. Flow
+$754M
Cap. Flow
% of AUM
4.96%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$124M |
| 2 |
Texas Instruments
TXN
|
+$113M |
| 3 |
UnitedHealth
UNH
|
+$106M |
| 4 |
Philip Morris
PM
|
+$106M |
| 5 |
TJX Companies
TJX
|
+$93.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$240M |
| 2 |
Zoetis
ZTS
|
+$221M |
| 3 |
Constellation Brands
STZ
|
+$123M |
| 4 |
Moody's
MCO
|
+$112M |
| 5 |
Estee Lauder
EL
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Consumer Discretionary | 12.3% |
| 3 | Technology | 11.57% |
| 4 | Communication Services | 10.98% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Boston Beer
SAM
$1.88B
| – | – |
-1,712
| Closed | -$266K |
|
|
SCHW
1102
Charles Schwab
SCHW
$180B
| – | – |
-207,518
| Closed | -$6.55M |
|
1103
Snap-on
SNA
$21B
| – | – |
-1,852
| Closed | -$281K |
|
1104
TD Synnex
SNX
$19.4B
| – | – |
-4,918
| Closed | -$281K |
|
1105
Sempra
SRE
$60B
| – | – |
-27,742
| Closed | -$1.49M |
|
1106
Stoneridge
SRI
$211M
| – | – |
-32,570
| Closed | -$599K |
|
1107
PUT
Sarepta Therapeutics
SRPT
$1.73B
| – | – |
-210,000
| Closed | -$8.96M |
|
1108
Steris
STE
$21.4B
| – | – |
-51,853
| Closed | -$3.79M |
|
1109
Stellantis
STLA
$16.4B
| – | – |
-72,203
| Closed | -$460K |
|
1110
Skyworks Solutions
SWKS
$9.39B
| – | – |
-18,567
| Closed | -$1.41M |
|
1111
AT&T
T
$167B
| – | – |
-1,172,565
| Closed | -$36M |
|
1112
Trip.com Group
TCOM
$28.3B
| – | – |
-369,626
| Closed | -$17.2M |
|
1113
Bio-Techne
TECH
$11.2B
| – | – |
-15,840
| Closed | -$434K |
|
1114
Teva Pharmaceuticals
TEVA
$36.1B
| – | – |
-231,251
| Closed | -$10.6M |
|
1115
Tenet Healthcare
THC
$21.1B
| – | – |
-60,518
| Closed | -$1.37M |
|
1116
Interface
TILE
$1.95B
| – | – |
-136,622
| Closed | -$2.28M |
|
1117
Teekay
TK
$972M
| – | – |
-45,626
| Closed | -$352K |
|
1118
Tempest Therapeutics
TPST
$15.3M
| – | – |
-4
| Closed | -$79K |
|
1119
Thomson Reuters
TRI
$42.5B
| – | – |
-34,364
| Closed | -$1.65M |
|
1120
T. Rowe Price
TROW
$25.4B
| – | – |
-14,233
| Closed | -$946K |
|
1121
Tronox
TROX
$965M
| – | – |
-246,853
| Closed | -$2.31M |
|
1122
TransUnion
TRU
$15B
| – | – |
-354,504
| Closed | -$12.2M |
|
1123
Tower Semiconductor
TSEM
$24.7B
| – | – |
-786,036
| Closed | -$11.9M |
|
1124
Ternium
TX
$9.29B
| – | – |
-67,233
| Closed | -$1.32M |
|
1125
Ulta Beauty
ULTA
$20.5B
| – | – |
-145,629
| Closed | -$34.7M |
|
Similar funds
Marshall Wace's Q4 2016 Portfolio in Review
As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $754M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.
- Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
- Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
- Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
- Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
- Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
- Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.
Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.